This FDA InspectorProfile is a report of relevant audit-related information on Daniel Lahar, a U.S. Food & Drug Administration investigator who primarily conducts inspections in the area of Medical Devices & Rad Health.
This InspectorProfile report is updated through and lists Daniel Lahar's inspections in 23 countries: Switzerland, Germany, Lithuania, United States, Netherlands, France, Italy, Sweden, United Kingdom, India, Australia, Costa Rica, Brazil, China, Korea (the Republic of), Taiwan, Dominican Republic (the), Canada, Thailand, Japan, Finland, Malaysia, and Belgium.
FDA audits are stressful. Whether you are issued a 483 depends largely on your compliance with GxP and predicate rules; but it can also depend on the Agency's current focus and the tendencies of your specific investigator(s). FDAzilla has curated Daniel Lahar's inspection information so that you can mitigate investigator-related risks.
Below is an example of what a FDAzilla InspectorProfile report contains; This is not the actual data for Daniel Lahar.
Note: The EIR and 483 documents are sold separately.